Endosomal fusion of pH-dependent enveloped viruses requires ion channel TRPM7.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 Oct 2024
Historique:
received: 16 04 2024
accepted: 19 09 2024
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 1 10 2024
Statut: epublish

Résumé

The majority of viruses classified as pandemic threats are enveloped viruses which enter the cell through receptor-mediated endocytosis and take advantage of endosomal acidification to activate their fusion machinery. Here we report that the endosomal fusion of low pH-requiring viruses is highly dependent on TRPM7, a widely expressed TRP channel that is located on the plasma membrane and in intracellular vesicles. Using several viral infection systems expressing the envelope glycoproteins of various viruses, we find that loss of TRPM7 protects cells from infection by Lassa, LCMV, Ebola, Influenza, MERS, SARS-CoV-1, and SARS-CoV-2. TRPM7 ion channel activity is intrinsically necessary to acidify virus-laden endosomes but is expendable for several other endosomal acidification pathways. We propose a model wherein TRPM7 ion channel activity provides a countercurrent of cations from endosomal lumen to cytosol necessary to sustain the pumping of protons into these virus-laden endosomes. This study demonstrates the possibility of developing a broad-spectrum, TRPM7-targeting antiviral drug to subvert the endosomal fusion of low pH-dependent enveloped viruses.

Identifiants

pubmed: 39353909
doi: 10.1038/s41467-024-52773-w
pii: 10.1038/s41467-024-52773-w
doi:

Substances chimiques

TRPM Cation Channels 0
TRPM7 protein, human EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8479

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI155808
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI163019
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI147394
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI112844
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI154598
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI030557
Organisme : NIAID NIH HHS
ID : T32 AI007245
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
ID : GM108989
Organisme : NIGMS NIH HHS
ID : T32 GM007267
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007055
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : HL170961

Informations de copyright

© 2024. The Author(s).

Références

Mercer, J., Schelhaas, M. & Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 79, 803–833 (2010).
pubmed: 20196649 doi: 10.1146/annurev-biochem-060208-104626
Yamauchi, Y. & Helenius, A. Virus entry at a glance. J. Cell Sci. 126, 1289–1295 (2013).
pubmed: 23641066
White, J. M. & Whittaker, G. R. Fusion of enveloped viruses in endosomes. Traffic 17, 593–614 (2016).
pubmed: 26935856 pmcid: 4866878 doi: 10.1111/tra.12389
Vigant, F., Santos, N. C. & Lee, B. Broad-spectrum antivirals against viral fusion. Nat. Rev. Microbiol. 13, 426–437 (2015).
pubmed: 26075364 pmcid: 4554337 doi: 10.1038/nrmicro3475
Wisskirchen, K., Lucifora, J., Michler, T. & Protzer, U. New pharmacological strategies to fight enveloped viruses. Trends Pharm. Sci. 35, 470–478 (2014).
pubmed: 25108320 doi: 10.1016/j.tips.2014.06.004
White, J. M. et al. Drug combinations as a first line of defense against coronaviruses and other emerging viruses. mBio 12, e0334721 (2021).
pubmed: 34933447 doi: 10.1128/mbio.03347-21
White, J., Kartenbeck, J. & Helenius, A. Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. J. Cell Biol. 87, 264–272 (1980).
pubmed: 7419594 doi: 10.1083/jcb.87.1.264
Fritz, R., Stiasny, K. & Heinz, F. X. Identification of specific histidines as pH sensors in flavivirus membrane fusion. J. Cell Biol. 183, 353–361 (2008).
pubmed: 18936253 pmcid: 2568029 doi: 10.1083/jcb.200806081
Lee, J., Gregory, S. M., Nelson, E. A., White, J. M. & Tamm, L. K. The roles of histidines and charged residues as potential triggers of a conformational change in the fusion loop of ebola virus glycoprotein. PLoS One 11, e0152527 (2016).
pubmed: 27023721 pmcid: 4811418 doi: 10.1371/journal.pone.0152527
Brecher, M. et al. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J. Virol. 86, 364–372 (2012).
pubmed: 22031933 pmcid: 3255896 doi: 10.1128/JVI.05708-11
Schornberg, K. et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174–4178 (2006).
pubmed: 16571833 pmcid: 1440424 doi: 10.1128/JVI.80.8.4174-4178.2006
Simmons, G. et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102, 11876–11881 (2005).
pubmed: 16081529 pmcid: 1188015 doi: 10.1073/pnas.0505577102
Wang, L., Wu, D., Robinson, C. V., Wu, H. & Fu, T. M. Structures of a complete human V-ATPase reveal mechanisms of its assembly. Mol. Cell 80, 501–511.e503 (2020).
pubmed: 33065002 pmcid: 7655608 doi: 10.1016/j.molcel.2020.09.029
Casey, J. R., Grinstein, S. & Orlowski, J. Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 11, 50–61 (2010).
pubmed: 19997129 doi: 10.1038/nrm2820
Chadwick, S. R., Grinstein, S. & Freeman, S. A. From the inside out: Ion fluxes at the centre of endocytic traffic. Curr. Opin. Cell Biol. 71, 77–86 (2021).
pubmed: 33706237 doi: 10.1016/j.ceb.2021.02.006
Abe, K. & Puertollano, R. Role of TRP channels in the regulation of the endosomal pathway. Physiol. (Bethesda) 26, 14–22 (2011).
Xu, H. & Ren, D. Lysosomal physiology. Annu. Rev. Physiol. 77, 57–80 (2015).
pubmed: 25668017 pmcid: 4524569 doi: 10.1146/annurev-physiol-021014-071649
Clapham, D. E. TRP channels as cellular sensors. Nature 426, 517–524 (2003).
pubmed: 14654832 doi: 10.1038/nature02196
Clapham, D. E. SnapShot: mammalian TRP channels. Cell 129, 220 (2007).
pubmed: 17418797 doi: 10.1016/j.cell.2007.03.034
Venkatachalam, K. & Montell, C. TRP channels. Annu. Rev. Biochem. 76, 387–417 (2007).
pubmed: 17579562 pmcid: 4196875 doi: 10.1146/annurev.biochem.75.103004.142819
Dong, X. P. et al. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455, 992–996 (2008).
pubmed: 18794901 pmcid: 4301259 doi: 10.1038/nature07311
Li, P., Gu, M. & Xu, H. Lysosomal ion channels as decoders of cellular signals. Trends Biochem. Sci. 44, 110–124 (2019).
pubmed: 30424907 doi: 10.1016/j.tibs.2018.10.006
Nadler, M. J. et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 411, 590–595 (2001).
pubmed: 11385574 doi: 10.1038/35079092
Runnels, L. W., Yue, L. & Clapham, D. E. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291, 1043–1047 (2001).
pubmed: 11161216 doi: 10.1126/science.1058519
Abiria, S. A. et al. TRPM7 senses oxidative stress to release Zn2+ from unique intracellular vesicles. Proc. Natl. Acad. Sci. USA 114, E6079–E6088 (2017).
pubmed: 28696294 pmcid: 5544332 doi: 10.1073/pnas.1707380114
Pelkmans, L. et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78–86 (2005).
pubmed: 15889048 doi: 10.1038/nature03571
Monteilh-Zoller, M. K. et al. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J. Gen. Physiol. 121, 49–60 (2003).
pubmed: 12508053 pmcid: 2217320 doi: 10.1085/jgp.20028740
Jiang, J., Li, M. & Yue, L. Potentiation of TRPM7 inward currents by protons. J. Gen. Physiol. 126, 137–150 (2005).
pubmed: 16009728 pmcid: 2266571 doi: 10.1085/jgp.200409185
Jin, J. et al. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science 322, 756–760 (2008).
pubmed: 18974357 pmcid: 2605283 doi: 10.1126/science.1163493
Jin, J. et al. The channel kinase, TRPM7, is required for early embryonic development. Proc. Natl. Acad. Sci. USA 109, E225–E233 (2012).
pubmed: 22203997 doi: 10.1073/pnas.1120033109
Sah, R. et al. Timing of myocardial trpm7 deletion during cardiogenesis variably disrupts adult ventricular function, conduction, and repolarization. Circulation 128, 101–114 (2013).
pubmed: 23734001 doi: 10.1161/CIRCULATIONAHA.112.000768
Schappe, M. S. et al. Chanzyme TRPM7 mediates the Ca(2+) influx essential for lipopolysaccharide-induced toll-like receptor 4 endocytosis and macrophage activation. Immunity 48, 59–74.e55 (2018).
pubmed: 29343440 pmcid: 5783319 doi: 10.1016/j.immuni.2017.11.026
Mendu, S. K. et al. Targeting the ion channel TRPM7 promotes the thymic development of regulatory T cells by promoting IL-2 signaling. Sci. Signal. 13, eabb0619 (2020)
Desai, B. N. et al. Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev. Cell 22, 1149–1162 (2012).
pubmed: 22698280 pmcid: 3397829 doi: 10.1016/j.devcel.2012.04.006
Krapivinsky, G., Krapivinsky, L., Manasian, Y. & Clapham, D. E. The TRPM7 chanzyme is cleaved to release a chromatin-modifying kinase. Cell 157, 1061–1072 (2014).
pubmed: 24855944 pmcid: 4156102 doi: 10.1016/j.cell.2014.03.046
Schappe, M. S. et al. Efferocytosis requires periphagosomal Ca(2+)-signaling and TRPM7-mediated electrical activity. Nat. Commun. 13, 3230 (2022).
pubmed: 35680919 pmcid: 9184625 doi: 10.1038/s41467-022-30959-4
Kang, Y. L. et al. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc. Natl. Acad. Sci. USA 117, 20803–20813 (2020).
pubmed: 32764148 pmcid: 7456157 doi: 10.1073/pnas.2007837117
Sakurai, Y. et al. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347, 995–998 (2015).
pubmed: 25722412 pmcid: 4550587 doi: 10.1126/science.1258758
Gunaratne, G. S., Yang, Y., Li, F., Walseth, T. F. & Marchant, J. S. NAADP-dependent Ca(2+) signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system. Cell Calcium 75, 30–41 (2018).
pubmed: 30121440 pmcid: 6251489 doi: 10.1016/j.ceca.2018.08.003
Ou, X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 11, 1620 (2020).
pubmed: 32221306 pmcid: 7100515 doi: 10.1038/s41467-020-15562-9
Dadonaite, B. et al. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike. Cell 186, 1263–1278.e1220 (2023).
pubmed: 36868218 pmcid: 9922669 doi: 10.1016/j.cell.2023.02.001
Prescott, J. B. et al. Immunobiology of Ebola and Lassa virus infections. Nat. Rev. Immunol. 17, 195–207 (2017).
pubmed: 28111475 doi: 10.1038/nri.2016.138
Simmons, J. A. et al. Ebolavirus glycoprotein directs fusion through NPC1+ endolysosomes. J. Virol. 90, 605–610 (2016).
pubmed: 26468524 doi: 10.1128/JVI.01828-15
Kim, I. S. et al. Mechanism of membrane fusion induced by vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. USA 114, E28–E36 (2017).
pubmed: 27974607
Roche, S. & Gaudin, Y. Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion. J. Virol. 78, 8746–8752 (2004).
pubmed: 15280482 pmcid: 479077 doi: 10.1128/JVI.78.16.8746-8752.2004
Li, S. et al. Acidic pH-induced conformations and LAMP1 binding of the lassa virus glycoprotein spike. PLoS Pathog. 12, e1005418 (2016).
pubmed: 26849049 pmcid: 4743923 doi: 10.1371/journal.ppat.1005418
Lee, J. et al. Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity. Proc. Natl. Acad. Sci. USA 114, E7987–E7996 (2017).
pubmed: 28874543 pmcid: 5617291 doi: 10.1073/pnas.1708052114
Di Simone, C. & Buchmeier, M. J. Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex. Virology 209, 3–9 (1995).
pubmed: 7747483 doi: 10.1006/viro.1995.1225
Lee, J. et al. Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry. Nat. Struct. Mol. Biol. 28, 181–189 (2021).
pubmed: 33462517 pmcid: 7992113 doi: 10.1038/s41594-020-00548-4
Turk, B. et al. Acidic pH as a physiological regulator of human cathepsin L activity. Eur. J. Biochem. 259, 926–932 (1999).
pubmed: 10092883 doi: 10.1046/j.1432-1327.1999.00145.x
Alwan, H. A., van Zoelen, E. J. & van Leeuwen, J. E. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. J. Biol. Chem. 278, 35781–35790 (2003).
pubmed: 12829707 doi: 10.1074/jbc.M301326200
Qin, X. et al. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels. Br. J. Pharm. 168, 1294–1312 (2013).
doi: 10.1111/bph.12012
Chubanov, V. & Gudermann, T. Mapping TRPM7 function by NS8593. Int. J. Mol. Sci 21, 7017 (2020)
Chubanov, V. et al. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. Br. J. Pharm. 166, 1357–1376 (2012).
doi: 10.1111/j.1476-5381.2012.01855.x
Rost, B. R. et al. Optogenetic acidification of synaptic vesicles and lysosomes. Nat. Neurosci. 18, 1845–1852 (2015).
pubmed: 26551543 pmcid: 4869830 doi: 10.1038/nn.4161
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280.e278 (2020).
pubmed: 32142651 pmcid: 7102627 doi: 10.1016/j.cell.2020.02.052
Bayati, A., Kumar, R., Francis, V. & McPherson, P. S. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem. 296, 100306 (2021).
pubmed: 33476648 pmcid: 7816624 doi: 10.1016/j.jbc.2021.100306
Koch, J. et al. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. EMBO J. 40, e107821 (2021).
pubmed: 34159616 pmcid: 8365257 doi: 10.15252/embj.2021107821
Birtles, D., Oh, A. E. & Lee, J. Exploring the pH dependence of the SARS-CoV-2 complete fusion domain and the role of its unique structural features. Protein Sci. 31, e4390 (2022)
Zang, R. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol. 5. https://doi.org/10.1126/sciimmunol.abc3582 (2020).
Graler, M. H. & Goetzl, E. J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18, 551–553 (2004).
pubmed: 14715694 doi: 10.1096/fj.03-0910fje
Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453–21457 (2002).
pubmed: 11967257 doi: 10.1074/jbc.C200176200
Galloway, S. E., Reed, M. L., Russell, C. J. & Steinhauer, D. A. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog. 9, e1003151 (2013).
pubmed: 23459660 pmcid: 3573126 doi: 10.1371/journal.ppat.1003151
Hu, Y. M., Sneyd, H., Dekant, R. & Wang, J. Influenza A virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target. Curr. Top. Med. Chem. 17, 2271–2285 (2017).
pubmed: 28240183 pmcid: 5967877 doi: 10.2174/1568026617666170224122508
Bouvier, N. M. & Lowen, A. C. Animal models for influenza virus pathogenesis and transmission. Viruses 2, 1530–1563 (2010).
pubmed: 21442033 pmcid: 3063653 doi: 10.3390/v20801530
De Clercq, E. & Li, G. Approved antiviral drugs over the past 50 years. Clin. Microbiol Rev. 29, 695–747 (2016).
pubmed: 27281742 pmcid: 4978613 doi: 10.1128/CMR.00102-15
Drose, S. & Altendorf, K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200, 1–8 (1997).
pubmed: 9023991 doi: 10.1242/jeb.200.1.1
Osei-Owusu, J. et al. Proton-activated chloride channel PAC regulates endosomal acidification and transferrin receptor-mediated endocytosis. Cell Rep. 34, 108683 (2021).
pubmed: 33503418 pmcid: 7869721 doi: 10.1016/j.celrep.2020.108683
Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3–20 (2022).
pubmed: 34611326 doi: 10.1038/s41580-021-00418-x
Kreutzberger, A. J. B. et al. Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease. J. Virol. 95, e0097521 (2021).
pubmed: 34406858 doi: 10.1128/JVI.00975-21
Case, J. B. et al. Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice. Cell Host Microbe 28, 465–474.e464 (2020).
pubmed: 32798445 pmcid: 7391951 doi: 10.1016/j.chom.2020.07.018
Whelan, S. P., Ball, L. A., Barr, J. N. & Wertz, G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA 92, 8388–8392 (1995).
pubmed: 7667300 pmcid: 41162 doi: 10.1073/pnas.92.18.8388
Case, J. B. et al. Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2. Cell Host Microbe 28, 475–485.e475 (2020).
pubmed: 32735849 pmcid: 7332453 doi: 10.1016/j.chom.2020.06.021
Fuerst, T. R., Niles, E. G., Studier, F. W. & Moss, B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122–8126 (1986).
pubmed: 3095828 pmcid: 386879 doi: 10.1073/pnas.83.21.8122
Aguet, F. et al. Membrane dynamics of dividing cells imaged by lattice light-sheet microscopy. Mol. Biol. Cell 27, 3418–3435 (2016).
pubmed: 27535432 pmcid: 5221578 doi: 10.1091/mbc.e16-03-0164
Chou, Y. Y. et al. Inherited nuclear pore substructures template post-mitotic pore assembly. Dev. Cell 56, 1786–1803.e1789 (2021).
pubmed: 34129835 pmcid: 8261643 doi: 10.1016/j.devcel.2021.05.015
Cabot, M., Kiessling, V., White, J. M. & Tamm, L. K. Endosomes supporting fusion mediated by vesicular stomatitis virus glycoprotein have distinctive motion and acidification. Traffic 23, 221–234 (2022).
pubmed: 35147273 pmcid: 10621750

Auteurs

Catherine A Doyle (CA)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Gregory W Busey (GW)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Wesley H Iobst (WH)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Volker Kiessling (V)

Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.
Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA.

Chloe Renken (C)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Hansa Doppalapudi (H)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Marta E Stremska (ME)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.

Mohan C Manjegowda (MC)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Mohd Arish (M)

Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA.
Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, USA.

Weiming Wang (W)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
Nikegen Inc., Shanghai, China.

Shardul Naphade (S)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Joel Kennedy (J)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Louis-Marie Bloyet (LM)

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.

Cassandra E Thompson (CE)

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.

Paul W Rothlauf (PW)

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Program in Virology, Harvard Medical School, Boston, MA, USA.

Eric J Stipes (EJ)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA.

Sean P J Whelan (SPJ)

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.

Lukas K Tamm (LK)

Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.
Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA.

Alex J B Kreutzberger (AJB)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Boston Children's Hospital, Boston, MA, USA.

Jie Sun (J)

Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA.
Division of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, USA.

Bimal N Desai (BN)

Department of Pharmacology, University of Virginia, Charlottesville, VA, USA. bdesai@virginia.edu.
Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA. bdesai@virginia.edu.
Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA. bdesai@virginia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH